SEC Filings :: Relmada Therapeutics, Inc. (RLMD)

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
04/06/26		Preliminary proxy statement not related to a contested matter or merger/acquisition			79
04/03/26		Registration statement under Securities Act of 1933 EX-3.1(V) EX-3.1(VI) EX-3.1(VII) EX-5.1 EX-23.1 EX-23.2 EX-FILING FEES			37
03/20/26		Current report EX-99.1 EX-99.2			52
03/19/26		Annual report [Section 13 and 15(d), not S-K Item 405] EX-23.1 EX-23.2 EX-31.1 EX-31.2 EX-32.1 EX-32.2			52
03/09/26		Current report EX-4.1 EX-10.1 EX-10.2 EX-99.1 EX-99.2 EX-99.3			95
02/17/26		Statement of Beneficial Ownership by Certain Investors EX-1			7
02/17/26		Statement of Beneficial Ownership by Certain Investors EX-99.1			7
02/12/26		Statement of Beneficial Ownership by Certain Investors EX-99.1			7
02/06/26		Statement of Beneficial Ownership by Certain Investors EX-24 EX-99			6
01/30/26		Prospectus [Rule 424(b)(5)]			1

rss_feed Filing RSS